These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15673723)

  • 1. Potent plasmodicidal activity of a heat-induced reformulation of deoxycholate-amphotericin B (Fungizone) against Plasmodium falciparum.
    Hatabu T; Takada T; Taguchi N; Suzuki M; Sato K; Kano S
    Antimicrob Agents Chemother; 2005 Feb; 49(2):493-6. PubMed ID: 15673723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.
    Chéron M; Petit C; Bolard J; Gaboriau F
    J Antimicrob Chemother; 2003 Dec; 52(6):904-10. PubMed ID: 14613963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective lysis of erythrocytes infected with the trophozoite stage of Plasmodium falciparum by polyene macrolide antibiotics.
    Wiehart UI; Rautenbach M; Hoppe HC
    Biochem Pharmacol; 2006 Mar; 71(6):779-90. PubMed ID: 16436272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
    J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
    Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
    Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro study of novel phospholipid micelles loaded with amphotericin B on plasmodium falciparum protozoan.
    Rajablou K; Attar H; Sadjady SK; Heydarinasab A
    Chem Phys Lipids; 2022 Jul; 245():105180. PubMed ID: 35247432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
    Adams ML; Andes DR; Kwon GS
    Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum: the fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. falciparum.
    Hatabu T; Hagiwara M; Taguchi N; Kiyozawa M; Suzuki M; Kano S; Sato K
    Exp Parasitol; 2006 Mar; 112(3):179-83. PubMed ID: 16384554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads.
    Jain J; Jain SK; Walker LA; Tekwani BL
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):40. PubMed ID: 28577368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.
    Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M
    Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of antifungal and cytotoxic activities as also the therapeutic safety of the oxidized form of amphotericin B.
    Klimek K; Strubińska J; Czernel G; Ginalska G; Gagoś M
    Chem Biol Interact; 2016 Aug; 256():47-54. PubMed ID: 27350166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of GM1 micelles-Amphotericin B interaction.
    Leonhard V; Alasino RV; Bianco ID; Garro AG; Heredia V; Beltramo DM
    Curr Drug Deliv; 2015; 12(4):406-14. PubMed ID: 25772153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.
    Rolón M; Serrano DR; Lalatsa A; de Pablo E; Torrado JJ; Ballesteros MP; Healy AM; Vega C; Coronel C; Bolás-Fernández F; Dea-Ayuela MA
    Mol Pharm; 2017 Apr; 14(4):1095-1106. PubMed ID: 28198632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
    Yu BG; Okano T; Kataoka K; Kwon G
    J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.